The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2875-2880

  Yaylim Eraltan, Ilhan ^a   Arikan, Soykan ^b   Yildiz, Yemliha ^a   Cacina, Canan ^a   Ergen, H Arzu ^a   Tuna, Gulay ^a   Görmüş, Uzay ^a   Zeybek, Ümit ^a   Isbir, Turgay ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul Research and Teaching and Research Hospital   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Colorectal cancer; Cyclin D1; Metastasis; Polymorphism; Risk

Indexed keywords

CYCLIN D1;

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLIN D1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; TURKEY; YOUNG ADULT;

EID: 77955832009     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Donnelan R and Chetty R: Cyclin D1 and human neoplasia. Mol Pathol 51: 1-7, 1998.
2. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA and Batsakis JG: PRAD-1 (CCND1)/cyclin D1oncogene amplication in primary head and neck squamous cell carcinoma. Cancer 74: 152-158, 1994.
3. Palmqvist R, Stenling R, Oberg A and Landberg G: Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 34: 1575-1581, 1998. (Pubitemid 28446340)
4. Marsh KL and Varley JM: Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer 77: 1460-1468, 1998.
5. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WD, Cerny T and Thatcher N: Prognostic signicance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br J Cancer 73: 294-300, 1996. (Pubitemid 26047506)
6. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB and Holt PR: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110: 669-674, 1996. (Pubitemid 26071834)
7. Lewis RC, Bostick RM, Xie D, Deng Z, Wargovich MJ, Fina MF, Ronfail WM and Geisinger KR: Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63: 8549-8553, 2003.
8. Le Marchand L, Seifried A, Lum-Jones A, Donlon T and Wilkens LR: Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 290(21): 2843-2348, 2003.
9. Betticher DC, Thatcher N, Antermatt HJ, Hoban P, Ryder WD and Heighway J: Alternate splicing produces a noval cyclin D1 transcript. Oncogene 11: 1005-1011, 1995.
10. Rogers S, Wells R and Rechsteiner M: Amino acid sequences common to rapidly degraded proteins the PEST hypothesis. Science 234: 364-368, 1986. (Pubitemid 17181385)
11. Sawa H, Ohshima TA, Ukita H., Murakami H, Chiba Y, Kamada H, Hara M and Saito I: Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16: 1701-1712, 1998. (Pubitemid 28175051)
12. Pakakasama S, Chen TT, Frawley W, Muller CY, Douglass EC, Lee R, Pollock BH and Tomlinson GE: CCND1 polymorphism and age of onset of hepatoblastoma. Oncogene 23(27): 4789-4792, 2004. (Pubitemid 38859467)
13. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J, Jones PW, Strange RC, Fryer AA and Hoban PR: Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 4: 2411-2418, 1998.
14. Greene Fl Page Dl Fleming ID, Fritz Ag Balch CM (eds.): AJCC Cancer Staging Handbook. 6th ed. New York: Springer-Verlag, p. 182, 2002.
15. Oh H-S, Chung H-J, Kim H-K and Choi J-S: Differences in overall survival when colorectal cancer patients are stratified into new TNM staging strategy. Cancer Res Treat 39(2): 61-64, 2007.
16. Compton CC, Greene FL: The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 54: 295-308, 2004.
17. Miller SA, Dykes DD and Polesky HS: Simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16: 1215-1219, 1988.
18. Lewis RC, Bostick RM, Xie D, Deng Z, Wargovich MJ, Fina M, Roufail WM and Geisinger KR: Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63: 8549-8553, 2003.
19. Ho YH and Ooi LLPJ: Recent advances in the total management of colorectal cancer, Ann Acad of Medi Singapore 32: 143-144, 2003. (Pubitemid 36827726)
20. Huang WS, Tang R, Lin PY, Changchien CR, Chen JS, Chiang JM, Yeh CY, Wang JY and Hsieh LL: Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum 49(5): 602-608, 2006. (Pubitemid 43723807)
21. De Kok TM and Van Maanen JM: Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat Res 463: 53-101, 2000. (Pubitemid 30326800)
22. Knudsen KE, Diehl JA, Haiman CA and Knudsen E: Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620-1628, 2006.
23. Sui J, Gao W, Li XJ, Ma J, Ren YX, Song X, Xiao CJ and Tang WR: Cyclin D1 gene G870A polymorphism and susceptibility to nasopharyngeal carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44(3): 227-31, 2009.
24. Satinder K, Chander SR, Pushpinder K, Indu G and Veena J: Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case-control study in north Indian population. Mol Cell Biochem 315(1-2): 151-157, 2008.
25. Catarino R, Matos A, Pinto D, Pereira D, Craveiro R, Vasconcelos A, Lopes C and Medeiros R: Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. Cancer Genet Cytogenet 160: 49-54, 2005. (Pubitemid 40798136)
26. Catarino RJ, Breda E, Coelho V, Pinto D, Sousa H, Lopes C and Medeiros R: Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck 25: 603-608, 2006. (Pubitemid 44025108)
27. McKay JA, Douglas JJ, Ross VG, Curran S, Murray GI, Cassidy J and McLeod HL: Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer 88: 77-81, 2000.
28. Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP and Yu MC: The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis 27(12): 2475-2482, 2006. (Pubitemid 44884106)
29. Hong Y, Eu KW, Seow-Choen F, Fook-Chong S and Cheah PY: GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 41: 1037-1044, 2005. (Pubitemid 40602856)
30. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O and Ozcelik H: Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(10): 2773-2781, 2008.
31. Bala S, Peltomäki P: Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 61: 6042-6045, 2001. (Pubitemid 32762536)
32. Kong S, Amos CI, Luthra R, Lynch PM, Levin B and Frazier ML: Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 60: 249-252, 2000. (Pubitemid 30070744)
33. Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J and Frazier ML: Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Nat Cancer Inst 93(14): 1106-1108, 2001. (Pubitemid 32717544)
34. Gazioglu NM, Erensoy N, Kadioglu P, Sayitoglu MA, Ersoy IH, Hatirnaz O, Kisacik B, Oz B, Sar M, Ozbek U, Ciplak N and Cagatay P: Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas. Med Sci Monit 13: CR457-463, 2007.
35. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS, Frazier ML, Spitz MR and Wei Q: Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22(8): 1195-1199, 2001. (Pubitemid 32737335)
36. Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Hunter DJ, Willett WC and Fuchs CS: Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer 94(6): 928-934, 2006.
37. Petre-Draviam CE, Williams EB, Burd CJ, Gladden A, Moghadam H, Meller J, Diehl JA and Knudsen KE: A central domain of cyclin D1 mediates nuclear receptor corepressor activity. Oncogene 24: 431-444, 2005. (Pubitemid 40188591)
38. McKay JA, Douglas JJ, Ros VG, Curran S, Ahmed FY, Loane JF, Murray GI and McLeod HL: Expression of cell cycle control proteins in primary colorectal tumors does nor always predict expression in lymph node metastases. Clin Cancer Res 6: 1113-1118, 2000. (Pubitemid 30159374)
39. Forones NM, de Lima JM, de Souza LG and da Silva ID: Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients. J Gastrointest Cancer 39(1-4): 118-123, 2008.
40. Fujita S, Shimoda T, Yoshimura K, Yamamoto S, Akasu T and Moriya Y: Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. J Surg Oncol 84: 127-131, 2003. (Pubitemid 37363154)